Sunday, April 14

Reversing Anticoagulation in Hemorrhagic Stroke; E-Cigs for Smoking Cessation

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, take a look at the leading medical stories of the week.

Today’s subjects consist of assigning donor hearts, an online program for long COVID, e cigarettes for cigarette smoking cessation, and reversing anticoagulation in hemorrhagic strokes.

Program notes:

0:40 Who gets a donor heart?

1:41 Circulatory support group

2:42 Assess brand-new standards

3:32 E-cigarettes in assisting individuals stop smoking

4:32 Validated abstaining at 6 months

5:32 Doesn’t stop nicotine usage

6:32 Deleterious impacts

7:01 Reversing anticoagulation in hemorrhagic stroke

8:01 Almost 10,000 such strokes

9:01 Not as much of a barrier to turnaround

9:20 Online program for long COVID

10:20 Health-related lifestyle result

11:20 Applied typically?

12:20 Related to deconditioning

13:06 End


Elizabeth: An online program for individuals with long COVID.

Rick: Justice in heart transplant.

Elizabeth: Can smokeless cigarettes really assist individuals stop utilizing nicotine?

Rick: And enhancing result and strokes due to bleeding.

Elizabeth: That’s what we’re discussing this weekend on TTHealthWatch, your weekly take a look at the medical headings from Texas Tech University Health Sciences Center in El Paso. I’m Elizabeth Tracey, a Baltimore-based medical reporter.

Rick: I’m Rick Lange, president of Texas Tech University Health Sciences Center in El Paso, where I’m likewise dean of the Paul L. Foster School of Medicine.

Elizabeth: Rick, I ‘d like to toss the ball directly to you. I ‘d like you to discuss this problem in JAMA about let’s call it equity with regard to heart transplants.

Rick: Heart transplant winds up being the favored treatment for individuals with sophisticated cardiac arrest. That’s since the 1-year survival after heart transplant is 90%. The conditional half life is 13 years, so we have actually truly made a great deal of advances with cardiac arrest. There aren’t adequate hearts to go around, and more than one-third of the prospects that are waiting for a heart transplant either pass away or they are gotten rid of from the waiting list without getting one.

Now, there is a company called UNOS, United Network for Organ Sharing, that attempts to designate these restricted hearts to make certain that the people that are more than likely to pass away get them. We have 6 various requirements that are presently utilized. You can control those. Now, one of them is you have to have particular what are called hemodynamic requirements. Let’s state you and I have the very same degree of innovative cardiac arrest, and they treat me with medications and they choose to put you on some mechanical circulatory support group.

ยป …
Find out more